OnKure Therapeutics, Inc. (OKUR)
2.37
-0.16
(-6.14%)
USD |
NASDAQ |
Nov 06, 10:13
OnKure Therapeutics Total Assets (Quarterly) : 167.08M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 167.08M |
| June 30, 2026 | 179.35M |
| March 31, 2026 | 198.69M |
| December 31, 2025 | 62.12M |
| September 30, 2025 | 72.84M |
| June 30, 2025 | 86.07M |
| March 31, 2025 | 99.88M |
| December 31, 2024 | 114.91M |
| September 30, 2024 | 77.64M |
| June 30, 2024 | 78.72M |
| March 31, 2024 | 84.64M |
| December 31, 2023 | 35.73M |
| Date | Value |
|---|---|
| September 30, 2023 | 130.39M |
| June 30, 2023 | 148.04M |
| March 31, 2023 | 98.87M |
| December 31, 2022 | 108.18M |
| September 30, 2022 | 122.50M |
| June 30, 2022 | 133.61M |
| March 31, 2022 | 144.41M |
| December 31, 2021 | 154.02M |
| September 30, 2021 | 162.94M |
| June 30, 2021 | 171.30M |
| March 31, 2021 | 95.32M |
| December 31, 2020 | 55.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 252.26M |
| Tonix Pharmaceuticals Holding Corp. | 254.09M |
| Karyopharm Therapeutics, Inc. | 111.32M |
| Minerva Neurosciences, Inc. | 95.09M |
| Corbus Pharmaceuticals Holdings, Inc. | 126.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.34M |
| Shareholders Equity (Quarterly) | 157.74M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 18.84 |
| Net Debt Paydown Yield | 0.01% |